Search clinical trials for: Cabotegravir LA + Rilpivirine LA

Total 235 results

Fundacion para la Formacion e Investigacion Sanitarias...
ViiV Healthcare

Recruiting

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months. (LOVER60)

HIV-1 Infected Adults with Controlled Viremia

Spain
ViiV Healthcare
Janssen, LP

Completed

A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed (SOLAR)

HIV Infections

United States, Netherlands, Germany, Canada, Australia, Belgium, France, Spain, Ireland, Italy, United Kingdom, Austria, Japan, Switzerland
National Institute of Allergy and Infectious Diseases...
ViiV Healthcare

Active, not recruiting

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents (MOCHA)

HIV Infections

Thailand, United States, Botswana, Uganda, South Africa
National Institute of Allergy and Infectious Diseases...
ViiV Healthcare

Active, not recruiting

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

HIV Infections

United States, Puerto Rico
ViiV Healthcare
GlaxoSmithKline; PPD DEVELOPMENT, LP

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy (VOLITION)

HIV Infections

United States, Germany, Spain, Canada, France, Italy, Puerto Rico, Argentina, Chile
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

Human Immunodeficiency Virus Type 1 (HIV-1)

United States, Spain, Canada, United Kingdom, South Africa, Japan
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Active, not recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

HIV Infections

United States, Netherlands, Spain, France, Germany, Canada, United Kingdom, South Africa, Italy, Russian Federation, Japan
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Active, not recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

HIV Infections | Infection, Human Immunodeficiency Virus

Spain, France, Germany, United States, Canada, Australia, Korea, Republic of, South Africa, Italy, Russian Federation, Sweden, Argentina, Mexico
Janssen Infectious Diseases BVBA

Completed

A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics

Human Immunodeficiency Virus Type 1

Belgium
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Active, not recruiting

Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+rilpivirine (HOLA)

HIV-1 Infection

Spain
Yale University
ViiV Healthcare

Recruiting

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

Hiv

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Pregnancy | HIV-1-infection | Postpartum

United States, South Africa
Boston Medical Center
ViiV Healthcare

Completed

Improving Treatment and Retention Adherence in Nontraditional Settings (I-TRAINS)

HIV Infections

United States
Lu Wang

Recruiting

CMRA for US-guided-MWA of Liver Tumors

Pain Control | Regional Anesthesia | Liver Tumors | Microwave Ablation

China
Philip Morris Products S.A.

Completed

Study to Investigate the Nicotine Pharmacokinetic Profiles and Pharmacodynamic Effects of P4M3 Variants

Vaping | Nicotine Absorption

United States
Kaohsiung Medical University

Completed

Hypochlorous Acid Mouthwash, Oral Bacteria, and Staphylococcus Aureus

Periodontal Diseases

Taiwan
Association of Urologic Oncology (AUO)
Eli Lilly and Company

Completed

Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA

Bladder Cancer

Germany
Riyadh Colleges of Dentistry and Pharmacy

Completed

Vital Signs Changes During Dental Procedures

Vital Signs Changes During Dental Procedures

Saudi Arabia
Eastern Hepatobiliary Surgery Hospital

Completed

Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Hepatocellular Carcinoma | Portal Vein Tumor Thrombus | Laser Ablation

China
National Cancer Center, Korea

Unknown

Endoscopic Full Thickness Resection With Laparoscopic Assistance (EFTR-LA)

Gastric Subepithelial Tumor

Korea, Republic of
Boston Children's Hospital

Suspended

Allogeneic Left Atrial and Pulmonary Vein Transplant for Pulmonary Vein Stenosis

Pulmonary Vein Stenosis

United States
ViiV Healthcare

Completed

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

HIV Infections

United States
ViiV Healthcare

Recruiting

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1 (CROWN)

HIV Infections

United States, Spain
Janssen Research & Development, LLC

Completed

A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants

Healthy

United States, Netherlands
MRC/UVRI and LSHTM Uganda Research Unit
London School of Hygiene and Tropical Medicine; Assistance Publique - Hôpitaux... and other collaborators

Not yet recruiting

Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa (MOBILEMEN)

HIV
Association of Urologic Oncology (AUO)

Unknown

Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy (SEAL)

Prostate Cancer

Germany
ViiV Healthcare
GlaxoSmithKline; PPD DEVELOPMENT, LP

Recruiting

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus) (PALISADE)

HIV Infections

Kenya, Argentina, Botswana, Brazil, Peru, South Africa, Thailand, Uganda
National Institute of Allergy and Infectious Diseases...
Gilead Sciences; ViiV Healthcare

Active, not recruiting

Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

HIV Infections

Brazil, United States, South Africa, Peru, Thailand, Argentina, Vietnam
Kaneka Medical America LLC

Recruiting

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System (FSGSALLAGE)

Focal Segmental Glomerulosclerosis

United States
Parc Sanitari Sant Joan de Déu

Completed

Homeless Population and Mental Health: Impact of Primer la Llar Program

Mental Health Disorder
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Infection, Human Immunodeficiency Virus

United States
University of Puerto Rico
The University of Texas Health Science Center, Houston

Completed

Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Puerto Rican Women (CLS)

Cervical Cancer | Breast Cancer

Puerto Rico
ViiV Healthcare
Janssen, LP

Completed

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

HIV Infections

United States, Canada
ViiV Healthcare

Active, not recruiting

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

HIV Infections

United States, Puerto Rico
Yonsei University

Completed

Impact of an 8-week Linoleic Acid Intake in Soy Oil on Lp-PLA2 Activity in Healthy Adults

Healthy Subjects

Korea, Republic of
University of Southern California
National Institute of Mental Health (NIMH); University of California, Los Angeles

Completed

Reducing the Duration of Untreated Psychosis (ReduceDUP)

First Episode Psychosis

United States
University of Puerto Rico
M.D. Anderson Cancer Center; National Cancer Institute (NCI); The University... and other collaborators

Completed

¡Salud! Por la Vida (SPLV) A Colorectal Screening Promotion Program (SPLV)

Colorectal Cancer

Puerto Rico
Shin Kong Wu Ho-Su Memorial Hospital

Unknown

The Study of the Efficacy of Laser Acupuncture on Osteoarthritis Knees by Using Magnetic Resonance Imaging, Clinical Evaluation, and Movement Analysis

Osteoarthritis, Knee

Taiwan
Japan Community Health Care Organization Sendai...

Unknown

Clinical Study to Evaluate the Efficacy of Blood Purification Therapy on Cholesterol Crystal Embolism

Cholesterol Embolism

Japan
Arizona State University

Completed

Madres Para la Salud (Mothers for Health)

Depression, Postpartum | Overweight and Obesity | Mother (Person)

United States
University of Extremadura

Completed

Use of Essential Oils as Natural Therapies

Skin Lesion | Dermatophytoses

Spain
University of Zurich

Active, not recruiting

High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)

Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Vascular Disease

Switzerland
Seoul National University Hospital

Recruiting

SCAR Burden of Left Atrium Guided cathEter Ablation sTrategy for Persistent Atrial Fibrillation (SCARLET-AF)

Atrial Fibrillation

Korea, Republic of
Jagiellonian University

Completed

Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy

Cushing's Syndrome | Pheochromocytoma | Adrenal Tumor | Conn's Syndrome

Poland
Astellas Pharma Inc
Toray Industries, Inc

Completed

Drug-Drug Interaction Study of TRK-100STP

Healthy

Japan
Wake Forest University Health Sciences
National Center for Complementary and Integrative Health (NCCIH); University... and other collaborators

Completed

Role of Polyunsaturated Fatty Acids (PUFA)-Gene Interactions in Heath Disparities

Fatty Acid-Gene Interactions

United States
NYU Langone Health
Department of Health and Human Services

Recruiting

Promoting Equitable Access to Language Services in Health and Human Services

Appropriate Use of Language Across Services

United States
SciVision Biotech Inc.

Completed

The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face

Lidocaine | Hyaluronic Acid | Dermal Filler | Aging Mid-Face

Taiwan
Yingfeng Zheng

Completed

Corneal Epithelial Autograft With Middle Lamellar Keratoplasty for Severe Ocular Burns

Ocular Burns

China
Vanderbilt University

Completed

ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity

Obesity | Diabetes

United States

Search clinical trials for: Cabotegravir LA + Rilpivirine LA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations